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Abstract 
 
Bioimpedance measurements with the Body Composition Monitor (BCM) have been shown 
to improve fluid management in haemodialysis. However, there is a lack of a sufficiently 
robust evidence-base for use of the BCM outside of standard protocols. This study aims to 
define the error associated with BCM measurement using alternate paths and timings to 
allow the use of BCM with confidence in a range of clinical scenarios. BCM measurements 
were made in 48 healthy controls and in 48 stable haemodialysis patients before and 
immediately after dialysis. The effect of utilising alternative measurement paths was 
assessed using mixed effects models and the effect of measuring post-dialysis was assessed 
by comparing changes in BCM-measured overhydration (OH) with weight changes over 
dialysis. The data from healthy controls suggest that there is no difference in BCM-
measured OH between all the whole-body paths other than the ankle-to-ankle 
measurement. Dialysis patients showed similar results other than having higher BCM-
measured OH when measured across the site of a vascular access. There was good 
agreement between BCM-measured OH from the standard path and change in weight, 
suggesting post-dialysis measurements can be utilised. These results suggest BCM protocols 
can be flexible regarding measurement paths and timing of measurement to ensure as many 
patients as possible can benefit from the technology. 
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Introduction 
Fluid management is an important part of care for haemodialysis patients (Wizemann et al., 
2009). There is growing evidence that the use of bioimpedance measurements with the 
body composition monitor (BCM; Fresenius Medical Care, Germany) can help guide fluid 
management and improve outcomes (Moissl et al., 2013, Onofriescu et al., 2014). However, 
there are few pragmatic studies that can help to inform the use of BCM outside of the strict 
protocol recommended for measurements and used in interventional studies, which can 
exclude a significant number of patients when BCM is used as part of routine care.  
 
DĂŶƵĨĂĐƚƵƌĞƌ ?ƐŐƵŝĚĂŶĐĞƐƚĂƚĞƚŚĂƚŵĞasurements should be made before dialysis with the 
patient in a supine position (Fresenius Medical Care, 2009). This is related to the effect that 
ultrafiltration (Abbas et al., 2014) and posture (Zhu et al., 1998) have on fluid distributions 
between  body segments and that, due to the different shapes and sizes of the limbs, shifts 
in fluid between segments  can have significant effects on the whole body impedance. 
Measurements should also be made from wrist-to-ankle  ? as this is the only validated 
measurement path  ? and should avoid peripheral access sites, due to the presence of 
anatomical changes. As such, the standard path that is supported by the BCM manufacturer 
is from wrist-to-ankle ŽŶƚŚĞŽƉƉŽƐŝƚĞƐŝĚĞŽĨƚŚĞďŽĚǇƚŽƚŚĞƉĂƚŝĞŶƚ ?ƐǀĂƐĐƵůĂƌĂĐĐĞƐƐ ? 
 
However, in practice these requirements would exclude a relatively large number of 
patients from having BCM measurements. The haemodialysis population is highly comorbid 
and is disproportionately prone to amputations and tissue viability problems. Heavily 
bandaged limbs, damaged skin and amputations can prevent the use of the standard 
measurement path, while some complications may not prevent a measurement but will 
significantly affect the quality of the measurement  ? e.g. use of moisturisers, localised fluid 
accumulations or contact between body segments such as at the armpit or between the 
legs. Validated alternative paths would allow measurements to be made on patients who 
would have otherwise have been managed without BCM or managed based on poor quality 
data. There are also a number of situations where it would be helpful to make post-dialysis 
BCM measurements. Practicalities and staffing levels can sometimes make it difficult to 
carry out all necessary BCM measurements at the same time as putting patients on dialysis, 
while post-dialysis measurements also allow immediate action to be taken when 
intradialytic symptoms prompt a review of target weights. 
 
The potential for the equivalence of impedance across different paths was demonstrated 
two decades ago using consecutive bioimpedance analysis (BIA) measurements on the right 
and left sides of the body (Lukaski et al., 1985)  ? although the approach to analysis in BIA 
differs considerably to that of bioimpedance spectroscopy (BIS) (Kyle et al., 2004), employed 
by the BCM. The only investigation to consider alternative paths with BIS measurements 
was in preliminary work for this study, where it was shown that BCM-measured 
overhydration (OH) from the wrist-to-wrist path is an acceptable alternative to the standard 
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path (Keane and Lindley, 2015). When considering post-dialysis measurements, it is 
accepted that haemodialysis induced changes in fluid distributions affect whole-body 
bioimpedance (Zhu et al., 1999), but the clinical significance of this when using BCM needs 
clarification.  
 
In order to allow greater understanding of the effect of making measurements outside the 
ŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐƉƌŽƚŽĐŽů on body composition parameters, this study aimed to characterise 
the error associated with alternate measurements that could be clinical useful. 
 
 
Methods 
 
Subjects 
Ethical approval was granted by a local ethics committee and all participants provided 
informed consent.  
 
A cohort of healthy controls was recruited (n=48), stratified by age-decade and by sex, who 
had no history of kidney disease or heart failure, no visible fluid accumulations and no limb 
amputations. Additionally, a cohort of stable haemodialysis patients was recruited (n=48), 
being over 18 years old, having no visible localised fluid accumulations and achieving target 
weight. Haemodialysis prescriptions were for regimes of three sessions of four hours per 
week, dialysate temperature was 36ࣙC and sodium was 137mmol/l as standard. Routine 
target weights were defined on the basis of clinical examination and BCM on indication. 
 
Sample size 
Pilot work comparing BCM measurements from wrist-to-wrist and from wrist-to-ankle 
showed standard deviations of the mean difference in OH of around 1.0 litres (Keane and 
Lindley, 2015). Recruiting 48 subjects into each cohort would allow differences of 0.3 litres 
to be measured between the primary two paths at the level of 5% type I error with 80% 
power using a two sided t-test. This is deemed an acceptable sample size; differences below 
0.3 litres will fall below the limits of reproducibility of the device (Wieskotten et al., 2013).  
 
Data collection 
Healthy controls had height measured using a stadiometer and weight measured using 
calibrated scales. For haemodialysis patients, height was taken from their clinical notes and 
pre- and post-dialysis weights were obtained as part of normal care.  
 
BCM measurements were made with the commercially available 4-electrode BCM on the 
standard path. For this, the impedance is measured between an electrode positioned on the 
wrist and an electrode on the ankle, while a small electric current is passed between two 
further electrodes positioned 10 cm distal to the measurement electrodes. Additionally, 
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measurements were made with a modified BCM - the 8-electrode BCM - which had 
additional cables allowing leads to be connected to electrodes on both hands and both feet. 
This device automatically makes 17 consecutive BIS measurements, varying the electrodes 
used for the voltage and current paths as described in figure 1. This allows measurement of 
impedances of the six whole body paths (figure 1, # 1-6), where the current and 
measurement electrodes define the same path through the body, as well as the impedances 
of individual segments (figure 1, # 11-16) (Gibson et al., 2008), where the measurement 
electrodes define a region of the body that is different from the path of the current, thereby 
isolating particular regions for measurement of segmental impedances.  4- and 8-electrode 
BCM measurements were made on healthy subjects on one occasion while dialysis patients 
had measurements made pre- and post-dialysis. All 4-lead BCM measurements were 
checked visually for artefacts, and repeated until the difference in measured OH was no 
greater than 0.2 litres between readings (in almost all cases the discrepancy between the 
first and second readings was no more than 0.1 litre). The 8-electrode device does not 
display Cole-plots or body composition data to allow real-time assessment of artefacts or 
consistency, so repeat measurements were not made. Measurements of resistance, 
reactance and phase angle were made at the same 50 frequencies as in the standard BCM, 
for seventeen combinations of voltage and current (see fig. 1) and data was extracted for 
analysis.  
 
# Voltage Current Segments measured  
 
 
1 RH-RF RH-RF Right arm, right trunk, right leg 
2 LH-LF LH-LF Left arm, left trunk, left leg 
3 RH-LF RH-LF Right arm, R-L trunk, left leg 
4 LH-RF LH-RF Left arm, L-R trunk, right leg 
5 RH-LH RH-LH Right arm, top trunk, left arm 
6 RF-LF RF-LF Right leg, low trunk, left leg 
7 RH-LF RH-RF Right arm, right trunk 
8 LH-RF LH-LF Left arm, left trunk 
9 LH-RF RH-RF Right leg, right trunk 
10 RH-LF LH-LF Left leg, left trunk 
11 RH-RF RH-LH Right arm 
12 LH-LF RH-LH Left arm 
13 RH-RF RF-LF Right leg 
14 LH-LF RF-LF Left leg 
15 LH-LF RH-RF Right trunk 
16 RH-RF LH-LF Left trunk 
17 RH-RF 
LH-LF 
RH-RF 
LH-LF 
Full whole body 
Figure 1: Specifications of an 8-electrode BCM measurement. RH, RF, LH, LF refer to right hand, 
right foot, left hand and left foot respectively.  
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8-electrode BCM data processing 
Programmes were written in Matlab (v. 2014a; Mathworks In, MA, USA) to process 8-
electrode BCM data. For each of the 17 measurements, the data was fitted to the Cole 
equation as described by De Lorenzo et al. (De Lorenzo et al., 1997) giving the extracellular 
fluid (ECF) resistance (RE) and intracellular fluid (ICF) resistance (RI). The main objectives 
were focussed on body composition parameters which can only be found from the whole 
body measurements (measurements 1-6) using volume and body composition models 
(Moissl et al., 2006, Chamney et al., 2007) for each individual path using optimised tissue 
hydration parameters  (courtesy of Fresenius Medical Care R&D). This provided equivalent 
data to the standard 4-lead BCM device, which was validated by processing 4-lead BCM 
impedance data with the custom analysis programme and comparing the results with those 
calculated by the device (see appendix 1). 
 
Mixed-effects regression model 
The use of mixed-effects regression allowed a model to be built that could account for the 
repeated measures on an individual from the 8-electrode BCM. This characterises the 
individual differences in fluid status and body composition and accounts for this when 
describing the differences between the paths at the cohort level.  
 
A different mixed effects model was used to analyse each of the principal BCM parameters - 
OH, lean tissue mass (LTM) and adipose tissue mass (ATM) - and the models only included 
measurements of the 6 whole-body paths: right side; left side; right wrist-to-left ankle (cross 
1); left wrist-to-right ankle (cross 2); wrist-to-wrist; and ankle-to-ankle. For healthy controls, 
subject was taken as the random effect and path, sex and age were taken as fixed effects.  
For haemodialysis patients, the same model set up was used, only with the addition of 
measurement time (pre- or post-dialysis), which was added as a simple predictor variable 
for the models of LTM and ATM and as an interaction term for the model of OH, to allow 
assessment of ultrafiltration associated changes in fluid distributions between the paths.  
 
To present the data, results for a 60 year old female measured on the standard path acted 
as a reference (standard path was taken as wrist-to-ankle on the dominant side of the body 
for controls and on and the contralateral side of the body to the most recently used vascular 
access (VA) for dialysis patients). The mean value for the dependent variable measured on 
the standard path is presented separately for controls and pre- and post-dialysis for 
patients, with a 95% confidence interval and a p-value assessing against a null value of zero. 
For each of the other measurement paths, the difference compared to the reference path is 
detailed with 95% confidence interval and a p-value. Adjustments for age and sex in each 
model are given and also for measurement time in the models assessing LTM and ATM. 
Significance levels were set at 0.05. 
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To examine each model, plots of standardised residuals against fitted values were used to 
check the assumption of homoscedasticity and a Q-Q plot of the residuals was used to 
assess normality. 
 
Statistical analysis 
To investigate the validity of post-dialysis measurements, the agreement between change in 
BCM-measured OH from the reference path and change in weight was assessed using Bland-
Altman analysis. Furthermore, the consistency of LTM and ATM from the start to end of 
dialysis was assessed based on the effect of measurement time in each of the mixed-effects 
models. 
 
The estimate of RE from the curve-fitting routine was used as a marker of relative changes in 
fluid status during dialysis for comparisons between the five body segments (right arm, left 
arm, trunk, right leg and left leg), where the whole-body analysis models are not 
appropriate.  
 
Bland Altman analysis was done using Analyse-it for Microsoft Excel (version 2.26). All other 
analyƐŝƐǁĂƐĚŽŶĞƵƐŝŶŐƚŚĞƐƚĂƚŝƐƚŝĐĂůƐŽĨƚǁĂƌĞƉĂĐŬĂŐĞ ‘Z ?ǀĞƌƐŝŽŶ ? ? ? ? ? ?Z&ŽƵŶĚĂƚŝŽŶĨŽƌ
Statistical Computing, Vienna, Austria).  
 
 
Results 
 
 Healthy controls 
n=48 
HD patients 
n=48 
Age (years) 49 (17) 60 (16) 
Height (m) 1.71 (0.11) 1.70 (0.12) 
Weight (kg) 73 (14) 81 (23) 
BMI (kg/m2) 25 (4) 29 (7) 
Sex (males) 24 (50%) 28 (58%) 
HD vintage (months) - 30 (6) 
Most recent VA (left sided) 
Albumin (g/L) 
Diabetes 
Number of comorbidities  - 1 
                                               - 2 
                                               - 3 
- 
- 
- 
- 
- 
- 
38 (79%) 
38 (2.8) 
14 (29%) 
12 (25%) 
4 (8%) 
3 (6%) 
Table 1: Subject demographics. Data are mean (standard deviation) for normal data and number 
(%) of subjects for categorical data. Comorbidities present included acute coronary syndrome, 
heart failure, cerebrovascular disease, liver disease, peripheral vascular disease and smoking. 
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Model results 
Patient characteristics can be seen in table 1. Details of model checking can be seen in 
Appendix 2. 
 
The results from the mixed effects regression models for OH can be seen in tables 2 and 3 
with the results for LTM and ATM in Appendix 3. For the models investigating OH and ATM, 
age and sex were not associated with OH, while both age and sex were associated with LTM 
in both healthy controls and haemodialysis patients. For the model of OH in dialysis 
patients, including measurement time as an interaction term made a significant difference 
compared to a model with measurement time as a simple predictor variable (p=0.02), 
indicating the effect of measurement time on OH is modulated by path. For the models of 
LTM and ATM, including measurement time as an interaction term did not make a 
difference to the model, suggesting that the effect of measurement time on LTM and ATM 
was not different between the paths. For these models, measurement time was included as 
a predictor variable to investigate the validity of post-dialysis measurements of LTM and 
ATM. 
  
 
Measurement  
Path 
OH  
(litres) 
Difference  
(litres) 
 
p-value 
Approx.  
95% CI 
Healthy 
controls 
Dominant -0.12 - 0.74 -0.86 to 0.61 
Non-dominant - 0.09 0.24 -0.06 to 0.25 
Cross1 - 0.002 0.98 -0.15 to 0.16 
Cross2 - 0.10 0.20 -0.05 to 0.26 
Arms - -0.02 0.81 -0.17 to 0.14 
Legs - 0.80 <0.01 0.64 to 0.95 
Table 2: Model for OH in healthy controls. Data are presented for a 60 year old female, where the 
adjustment for OH with age was -0.003 per year (p=0.65; 95% CI: -0.02 to 0.01) and with sex was 
0.28 for male (p=0.22; 95% CI: -0.17 to 0.74). Difference is relative to the dominant path. 
 
Measurement  
Path 
OH  
(litres) 
Difference  
(litres) 
 
p-value 
Approx.  
95% CI 
Pre-
dialysis 
Non-VA side 1.7 - <0.01 0.66 to 2.7 
VA-side - 0.42 0.02 0.08 to 0.76 
Cross1 - 0.02 0.91 -0.32 to 0.36 
Cross2 - 0.41 0.02 0.07 to 0.75 
Arms - -0.21 0.23 -0.55 to 0.13 
Legs - 1.7 <0.01 1.4 to 2.1 
Post-
dialysis 
Non-VA side -0.12 - 0.82 -1.2 to 0.90 
VA-side - 0.13 0.61 -0.36 to 0.61 
Cross1 - 0.02 0.93 -0.46 to 0.50 
Cross2 - 0.10 0.68 -0.38 to 0.59 
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Arms - 0.35 0.16 -0.13 to 0.84 
Legs - -0.56 0.03 -1.0 to -0.07 
Table 3: Model for OH in dialysis patients. Data are presented for a 60 year old female, where the 
adjustment for OH with age was 0.012 per year (p=0.38; 95% CI: -0.02 to 0.04) and with sex was 
0.001 for male (p=0.99; 95% CI: -0.88 to 0.89). Difference is relative to the non-VA side. 
 
Use of alternate paths 
The data from healthy controls show that there is no difference in BCM-measured OH 
between all the whole-body paths other than the ankle-to-ankle measurement, which had a 
difference of 0.8 litres (table 2). Considering LTM and ATM, there was a significant 
difference between the reference path and most other paths, apart from the cross 
measurements, including higher LTM and lower ATM in the dominant arm and in the wrist-
to-wrist path as compared to the reference path.  
 
Haemodialysis patients showed different pre-dialysis patterns than subjects with normal 
renal function. In particular, there was a significant difference in pre-dialysis BCM-measured 
OH between the side of the body where vascular access was situated as compared to the 
contralateral side (0.4 litres; 95% CI: 0.08 to 0.76; table 3), although this effect was not 
present post-dialysis. Unlike controls, there was no difference in LTM or ATM between the 
sides (Appendix 3), despite the fact that vascular access is usually on the non-dominant side. 
 
Using the 8-electrode BCM, the impedances of each limb individually can be isolated (figure 
1), which can support the results of the regression models. The relative magnitudes of RE 
and RI in each limb expressed in relation to the corresponding value from the reference path 
(whole body measurement on dominant/non-VA side) can be seen in table 4. Estimation of 
RI has much greater uncertainty and for segmental measurements, especially, in the trunk, 
the data were largely uninformative. 
 
 
Segment 
Control Pre-dialysis Post-dialysis p-value 
RE RI RE RI RE RI RE RI 
Arm_ref (%) 52 56 50 55 48 54 0.02 0.6 
Arm_opp (%) 52 59 52 51 50 53 0.06 <0.01 
Leg_ref (%) 44 47 44 51 45 50 0.4 0.4 
Leg_opp (%) 44 48 43 55 45 52 0.5 0.3 
Trunk_ref (%) 4.0 1.4 4.3 1.6 4.1 1.3 0.2 0.3 
Trunk_opp (%) 4.0 1.3 4.0 1.5 3.8 1.6 0.3 0.6 
Trunk upper (%) 0.2 - 0.3 - 0.1 - 0.8 - 
Trunk lower (%) 0.01 - 0.03 - 0.03 - 0.8 - 
Trunk_ref-opp (%) 4.0 - 4.1 - 3.8 - 0.3 - 
Trunk_opp-ref (%) 4.0 - 4.1 - 3.8 - 0.3 - 
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Table 4: Relative segmental resistances as a proportion of standard whole body path resistances. 
Between group differences for RE and RI were assessed using one-way ANOVA.  ‘ZĞĨ ?ŝŶĚŝĐĂƚĞƐĂ
segment from the reference path,  ‘ŽƉƉ ?ĨƌŽŵƚŚĞŽƉƉŽƐŝƚĞƐŝĚĞĂŶĚƌĞĨ-opp/opp-ref come from 
cross measurements. 
 
Use of post-dialysis measurements 
There was good agreement between change in BCM-measured OH on the reference 
measurement path ([pre-dialysis OH]  ? [post-dialysis OH]) with change in weight (fig. 2; bias 
0.3 kg, 95% CI -1.9 to 1.3 kg). In theory, LTM and ATM should not change over dialysis and 
although there was no significant change in LTM (-0.40 kg; p=0.1; 95% CI:-1.1 to 0.1; table A3) 
there was a difference observed for ATM (0.77 kg; p=0.01; 95% CI: 0.16 to 1.4; table A4).  
 
 
Figure 2: Bland Altman analysis of the agreement of change in weight and change in OH 
 
The use of measurement time as an interaction term in the models for dialysis patients 
showed that measured-OH changed by a different amount between the paths. The only 
statistically significant interaction was for the ankle-to-ankle path, which suggests that there 
is a greater change in BCM-measured OH across this path compared to the other paths. This 
is supported by looking at the segmental impedance data. If relative changes in RE over 
dialysis are used to indicate changes in fluid status, it can be seen that the greatest relative 
change is in the leg segments (table 5).  
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Mean post  
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Mean % change  
in RE (Ohms) 
Arm_ref 288 (68) 326 (69) 13 (9) 
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Table 5: Segmental changes in ECF resistance (RE) over dialysis with a mean ultrafiltration volume 
of 1.9 litres ? ‘RĞĨ ?ŝŶĚŝĐĂƚĞƐĂƐĞŐŵĞŶƚĨƌŽŵƚŚĞƌĞĨĞƌĞŶĐĞƉĂƚŚĂŶĚ ‘ŽƉƉ ?ĨƌŽŵƚŚĞŽƉƉŽƐŝƚĞƐŝĚĞ ? 
 
Discussion 
 
Rationale for the need for flexible measurement protocols 
At a population level, it is becoming well accepted that using BCM as an aide in guiding fluid 
management in haemodialysis improves outcomes (Onofriescu et al., 2014, Moissl et al., 
2013). In an uncomplicated individual with relatively common characteristics, standard 
measurement protocols - from wrist-to-ankle on one side of the body avoiding vascular 
access sites - and decision making algorithms are likely to be beneficial. Yet there is a lack of 
data to support use of BCM outside this standardised approach and there remains a great 
deal of uncertainty in utilisation of the technology in certain individuals. By making 8-
electrode BCM measurements on healthy controls and dialysis patients, the effect of making 
a number of simple alterations to BCM measurements are characterised which will allow 
these measurements to be made with greater confidence. 
 
Use of alternate paths 
Measurements on healthy controls suggest there is no significant difference in OH from any 
whole-body path other than across the legs. In principle the models that were generated 
and validated for the standard path can be employed with alternate paths. Changing from a 
standard wrist-to-ankle measurement on one side of the body to a wrist-to-wrist or cross 
measurement will involve substitution of one limb for another and a change in the pathway 
through the trunk. Using the segmental resistances from dialysis patients in table 4, the 
different path resistances can be built from the segments and referenced to the standard 
path (figure 3). For measurements of RE, substituting limbs and trunk paths does not 
significantly alter the overall path RE, for any of the whole body paths except the ankle-to-
ankle path which is noticeably lower, consistent with results from the regression model. For 
the wrist-to-wrist path, the higher resistance of the arms seems to be compensated by a 
lower measured resistance for a current crossing the trunk from wrist-to-wrist than from 
wrist-to-ankle.  
Arm_opp 283 (71) 316 (73) 12 (8) 
Trunk 23 (7) 25 (5) 6 (7) 
Leg_ref 248 (63) 295 (73) 19 (8) 
Leg_opp 247 (63) 294 (73) 19 (7) 
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Figure 3: Re-calculating whole-body assessments of RE expressed as a % of the standard 
measurement path (wrist-to-ankle on the dominant side) in healthy controls based on the data in 
table 5 
 
For haemodialysis patients, it has been suggested that the presence of vascular access in a 
ƉĂƚŝĞŶƚƐ ?ĂƌŵĐĂŶďŝĂƐŵeasurements of OH and so guidance suggests avoiding these paths. 
The evidence supporting this recommendation comes from studies using different 
bioimpedance with different analysis techniques to the BIS used in the BCM. Woodrow et al. 
used whole-body, single frequency BIA measurements to show decreased resistance in the 
fistula arm that was accompanied by increased arm circumference, suggesting increased 
excess fluid (Woodrow et al., 1997), although this was not replicated in paediatrics (Avila et 
al., 2015). More recently, two studies from a single centre using segmental BIA (SBIA) have 
reported that water and lean tissue content is different in the fistula and non-fistula arms 
(Panorchan et al., 2015, Booth et al., 2011). However, neither BIA or SBIA can adequately 
distinguish excess fluid from lean and adipose tissue, which left the possibility that the 
differences observed relate to differences in lean tissue alone rather than excess fluid, 
particularly given that fistulae tend to be placed in the non-dominant arm of patients. The 
results here confirm that the presence of a vascular access does tend to increase OH. 
However, the effect (mean: 0.4; 95% CI: 0.1 to 0.8 litres) is arguably negligible from a clinical 
perspective, when considering the overall uncertainty in target weight prescription. 
 
Considering the model results for LTM and ATM in controls, it is important to note that the 
equivalence of OH across different paths does not translate to these compartments. Where 
accurate monitoring of body composition is important, the standard pathway is preferred 
and consistency is important. The dominant side has significantly increased LTM and 
reduced ATM as compared to the non-dominant side and the legs have increased LTM and 
reduced ATM compared to the arms (see Appendix 3). This is consistent with previous work 
using BIA on controls that demonstrated decreased resistance in the dominant arm 
compared to the non-dominant arm (Bedogni et al., 2002) and a decreased resistance of the 
Dominant side: 100% 
Non-dominant side: 101% 
 
Cross 1: 101% 
Cross 2: 101% 
Arms: 104% 
Legs: 89% 
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legs compared to the arms (Lorenzo and Andreoli, 2003) as decreased resistance is linked 
with greater muscle mass through the higher proportion of water in muscle than fat.  
 
Use of post-dialysis measurements 
Considering the use of post-dialysis BCM measurements, change in body weight was 
compared to change in BCM-measured OH as there is no accepted gold standard measure of 
OH to validate post-dialysis measurements.  In theory, the change in OH over dialysis should 
equal the change in body weight, while there should be no change in LTM or ATM. However, 
dialysis has been shown to perturb fluid distributions (Shulman et al., 2001) which can 
influence whole-body bioimpedance measurements (Zhu et al., 1999). Fluid shifts from the 
limbs into the trunk manifest as an apparent decrease in ECF when measured by whole-
body techniques and shifts from the trunk to the limbs as an increase in ECF (Lundvall et al., 
1996).  
 
The results here suggest that post-dialysis BCM-measured OH has a small bias of around 0.3 
litres, with limits of agreement of -1.9 to 1.3 litres. This supports the validation literature of 
the BCM which has shown that the change in BCM-measured OH over dialysis is comparable 
to the ultrafiltration volume (Wabel et al., 2007). There are reasonably large limits of 
agreement which should be taken into account when making post-dialysis measurements, 
but these measurements were taken immediately after dialysis and it is reasonable to 
assume that they would be reduced if there was a time delay introduced between dialysis 
end and BCM measurement, as recommended by the manufacturer. El-Kateb et al. reported 
a similar dataset to that presented here (El-Kateb and Davenport, 2015) with contrasting 
results, including a significant bias and limits of agreement three times larger than those 
observed in this study. This discrepancy seems likely to be due to artefactual BCM 
measurements and highlights the need for some expertise when making measurements 
(Lindley et al., 2015). The BCM validation literature also suggests that a bias is introduced 
into measurements of LTM and ATM when measurements are made immediately after 
dialysis but within 30 minutes this becomes non-significant. Considering this, and the 
findings here, users should have a degree of caution using BCM-measured LTM and ATM 
from post-dialysis measurements.  
 
Despite the good agreement between change in BCM-measured OH and change in weight, 
the model for OH did suggest there was a degree of ultrafiltration induced changes in fluid 
distribution, with a larger change in the lower limbs than the upper. This would suggest that 
relatively more fluid is recruited from the legs than the upper body which is largely in 
agreement with previous work. Measurements over the first 75 minutes of dialysis using BIS 
(Shulman et al., 2001) and over the whole haemodialysis session using SBIA (Zhu et al., 
2008) and segmental BIS (Chanchairujira and Mehta, 2001) have demonstrated a greater 
fractional change in fluid in the legs as compared to arms and trunk. Abbas et al (Abbas et 
al., 2014) showed that there is a greater percentage removal of ECF from the legs than other 
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compartments but that as ultrafiltration rate is increased, there is a preferential recruitment 
of fluid from the trunk.  
 
Study limitations 
The study was not powered to address the multiple comparisons made by the models - the 
sample size was based on comparisons between the two primary whole-body paths only. A 
larger sample would allow better estimates of these different estimates. It would also have 
been interesting to extend the analysis to a group of haemodialysis patients who are 
defined as being prone to intradialytic hypotension (IDH), to investigate the relationship 
between fluid distributions, fluid dynamics and IDH. 
 
Conclusions 
 
In summary, these data helps BCM users make measurements and interpret results with 
greater confidence. Measurement protocols can be more flexible and individualised than 
ƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŐƵŝĚĂŶĐĞƐƵŐŐĞƐƚƐ, which will help as many patients as possible benefit 
from the technology. This is based on a number of key observations: 
x Any of the whole body paths other than ankle-to-ankle can be used as an alternative 
to the standard path for measurement of OH by BCM, with an acknowledgement of 
the additional uncertainty when interpreting the results. 
x BCM-measured OH is greater when measuring across a site of vascular access, but 
the increase arguably is not clinically significant when the uncertainty in other 
methods of target weight assessment is considered.  
x Making BCM measurements post-dialysis introduces a negligible bias to OH 
measurements but does increase measurement uncertainty, which should be 
accounted for when interpreting such data. This uncertainty will be reduced with 
time after dialysis, such as asking patients to move off the dialysis station to be 
weighed, before a measurement is made. 
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Appendix 1 
The bespoke analysis programme for the 8-electrode BCM data was validated by re-
analysing data that had been used in standard BCM measurements. The raw data from 
twenty measurements on subjects with a wide variety of body composition and fluid status 
(mean (range) of BMI: 29 (16 to 50) kg/m2; and of OH 0.5 (-3.8 to 5.9) litres) were analysed 
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with the programme and the agreement between the body composition parameters can be 
seen in figure A1. For OH, the bias was 0.1 litres with 95% limits of agreement of around -0.1 
to 0.3, showing very good agreement and verifying that the programmes are working 
similarly to commercial device analysis. For LTM and ATM, biases of -0.4 and 0.3 litres were 
observed with slightly larger confidence intervals. This is likely to be related to known issues 
in modelling RI which has a larger influence on LTM and ATM than OH. However, for the 
purposes of the study LTM and ATM are secondary outcome interests and the agreement 
was deemed sufficient. 
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Figure A1 PsĂůŝĚĂƚŝŶŐƚŚĞĚĂƚĂĂŶĂůǇƐŝƐƉƌŽŐƌĂŵŵĞĂŐĂŝŶƐƚĐŽŵŵĞƌĐŝĂůĂŶĂůǇƐŝƐĨŽƌK, ?Ť ? ? LTM  ?Ťŝ ? ?
ATM  ?Ťŝŝ ?ƵƐŝŶŐůĂŶĚ-Altman analysis 
(i) 
(ii) 
(iii) 
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Appendix 2 
The results from checks of each of the models can be seen in figures A2 - A4. Visual 
inspection of the residual plots suggested random scatter. Although Q-Q plots showed some 
dispersion from normality; sensitivity analyses were done by checking the outliers for errors, 
but no clear problems with the data were found.  
 
 
&ŝŐƵƌĞ ? PWůŽƚŽĨƌĞƐŝĚƵĂůƐ ?ůĞĨƚ ?ĂŶĚĂ ‘Y-Y ?ƉůŽƚŽĨƚŚĞƌĞƐŝĚƵĂůƐ ?ƌŝŐŚƚ ?ĨŽƌŵŝǆĞĚ-effects model of 
OH in healthy controls (above) and haemodialysis patients (below). See appendix 2 for similar 
plots of the models for LTM and ATM 
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Figure A3 PWůŽƚŽĨƌĞƐŝĚƵĂůƐ ?ůĞĨƚ ?ĂŶĚĂ ‘Y-Y ?ƉůŽƚŽĨƚŚĞƌĞƐŝĚƵĂůƐ ?ƌŝŐŚƚ ?ĨŽƌŵŝǆĞĚ-effects model of 
LTM in healthy controls (above) and haemodialysis patients (below) 
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Figure A4 PWůŽƚŽĨƌĞƐŝĚƵĂůƐ ?ůĞĨƚ ?ĂŶĚĂ ‘Y-Y ?ƉůŽƚŽĨƚŚĞƌĞƐŝĚƵĂůƐ ?ƌŝŐŚƚ ?ĨŽƌŵŝǆĞĚ-effects model of 
ATM in healthy controls (above) and haemodialysis patients (below)Results of the mixed models 
for LTM and ATM for both healthy controls and dialysis patients. 
 
 
Appendix 3 
 
Results of the regression models for LTM and ATM for healthy controls (Tables A1 and A2) 
and dialysis patients (Tables A3 and A4). 
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Measurement  
Path 
LTM  
(kg) 
Difference  
(kg) 
 
p-value 
Approx. 95% 
CI 
Healthy 
controls 
Dominant 45 - <0.01 39 to 50 
Non-dominant - -1.5 <0.01 -2.5 to -0.4 
Cross1 - -0.43 0.41 -1.4 to 0.59 
Cross2 - -1.1 0.05 -2.1 to -0.03 
Arms - -2.7 <0.01 -3.7 to -1.7 
Legs - 4.4 <0.01 3.4 to 5.4 
Table A1: Model for LTM in healthy controls. Data are presented for a 60 year old female, where 
the adjustment for LTM with age was -0.17 per year (p<0.01; 95% CI: -0.28 to -0.07) and with sex 
was 19 for male (p<0.01; 95% CI: 15 to 22) 
 
 
Measurement  
Path 
ATM  
(kg) 
Difference  
(kg) 
 
p-value 
Approx. 95% 
CI 
Healthy 
controls 
Dominant 23 - <0.01 12 to 35 
Non-dominant - 1.4 <0.01 0.36 to 2.4 
Cross1 - 0.44 0.40 -0.57 to 1.5 
Cross2 - 0.95 0.07 -0.06 to 2.0 
Arms - 2.7 <0.01 1.7 to 3.7 
Legs - -5.2 <0.01 -6.3 to -4.2 
Table A2: Model for ATM in healthy controls. Data are presented for a 60 year old female, where 
the adjustment for ATM with age was 0.11 per year (p=0.33; 95% CI: -0.11 to -0.32) and with sex 
was -2.7 for male (p=0.44; 95% CI: -9.7 to 4.2)  
 
 
Measurement  
Path 
LTM  
(kg) 
Difference  
(kg) 
 
p-value 
Approx. 95% 
CI 
Pre-
dialysis 
Non-VA side 29 - <0.01 25 to 33 
VA-side - 0.36 0.50 -0.68 to 1.4 
Cross1 - -0.31 0.55 -1.4 to 0.73 
Cross2 - 0.74 0.17 -0.31 to 1.8 
Arms - 1.2 0.03 0.16 to 2.3 
Legs - 1.6 <0.01 0.57 to 2.6 
Table A3: Model for LTM with dialysis patients. Data are presented for a 60 year old female, where 
the adjustment for LTM with age was -0.40 per year (p<0.01; 95% CI: -0.56 to -0.25), with sex was 
17 for male (p<0.01; 95% CI: 12 to 22) and with post-dialysis measurements was -0.40 kg; p=0.1; 
95% CI:-1.1 to 0.1 as compared to pre-dialysis 
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Measurement  
Path 
ATM  
(kg) 
Difference  
(kg) 
 
p-value 
Approx. 95% 
CI 
Pre-
dialysis 
Non-VA side 39 - <0.01 30 to 47 
VA-side - -0.86 0.11 -1.9 to 0.19 
Cross1 - 0.27 0.61 -0.78 to 0.33 
Cross2 - -1.2 0.02 -2.3 to -0.17 
Arms - -1.2 0.03 -2.2 to -0.11 
Legs - -3.1 <0.01 -4.2 to -2.1 
Table A4: Model for ATM in dialysis patients. Data are presented for a 60 year old female, where 
the adjustment for ATM with age was 0.15 per year (p=0.40; 95% CI: -0.20 to 0.50), with sex was 
3.9 for male (p=0.50; 95% CI: -7.5 to 15) and with post-dialysis measurements was 0.77 kg; p=0.01; 
95% CI: 0.16 to 1.4 as compared to pre-dialysis 
 
Appendix 4 
Abbreviation Description 
ATM 
BCM 
BIA 
BIS 
BMI 
ECF 
ICF 
IDH 
LTM 
OH 
RE 
RI 
SBIA 
VA 
Adipose tissue mass 
Body Composition Monitor 
Bioimpedance analysis 
Bioimpedance spectroscopy 
Body mass index 
Extracellular fluid 
Intraceullular fluid 
Intradialytic hypotension 
Lean tissue mass 
Overhydration 
Extracellular resistance 
Intracellular resistance 
Segmental bioimpedance analysis 
Vascular access 
Table A5: Abbreviations 
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